Systematic review / meta-analysis / 2019
Resveratrol supplementation significantly reduced serum CRP levels in adults, but showed no overall effect on IL-6 or TNF-α.
A systematic review and meta-analysis of 15 randomized controlled trials evaluated the effects of resveratrol supplementation in 658 adults aged 18 to 75 years. Resveratrol significantly reduced serum CRP levels (WMD = -0.54; 95% CI: -0.78, -0.30; P < 0.0001), but had no overall significant effect on IL-6 (WMD = -0.06; 95% CI: -0.27, 0.14) or TNF-α (WMD = -0.20; 95% CI: -0.55, 0.16). Subgroup analyses found resveratrol intake reduced TNF-α in young subjects (WMD = -0.34; 95% CI: -0.57, -0.12) and obese individuals (WMD = -1.52; 95% CI: -2.87, -0.16). High heterogeneity was present across the analyses.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 658 adults aged 18–75 years across 15 trials
- What was measured
- Serum inflammatory mediators (CRP, IL-6, TNF-α)
THE PAPER
Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials.
Haghighatdoost F, Hariri M. Eur J Clin Nutr, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.